Accounting for about 2% of NPM1-mutant-related diseases, NPM1-mutation in MDS has been associated with a higher risk of secondary AML and is most commonly found in MDS with an excess blast (MDS-EB) [53,54]. Here, NPM1 is linked to myelodysplastic syndrome.